Japanese approval for GSK’s COPD drug; EU filling – The Pharma Letter (registration)


The Pharma Letter (registration)

Japanese approval for GSK's COPD drug; EU filling
The Pharma Letter (registration)
The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Relvar Ellipta (fluticasone furoate/vilanterol 100/25mcg) for the relief of various symptoms with chronic obstructive pulmonary disease (chronic bronchitis, pulmonary emphysema) (in ...
GSK Files Regulatory Submission in EU for Triple Combination Therapy on COPDRTT News
Glaxo files marketing application in Europe for inhaled triple combo COPD therapySeeking Alpha
GlaxoSmithKline Files EU Regulatory Submission For COPD TreaLondon South East (registration) (blog)

all 10 news articles »

GSK Files Regulatory Submission In EU For Triple Combination Therapy On COPD – Nasdaq


The Pharma Letter (registration)

GSK Files Regulatory Submission In EU For Triple Combination Therapy On COPD
Nasdaq
The EU regulatory submission of closed triple therapy comprises a Marketing Authorisation Application for a maintenance treatment to relieve symptoms of adult patients with COPD. It is based on data from the closed triple combination therapy ...
Japanese approval for GSK's COPD drug; EU fillingThe Pharma Letter (registration)
Glaxo files marketing application in Europe for inhaled triple combo COPD therapySeeking Alpha

all 10 news articles »

GSK Files Regulatory Submission In EU For Triple Combination Therapy On COPD – Nasdaq


The Pharma Letter (registration)

GSK Files Regulatory Submission In EU For Triple Combination Therapy On COPD
Nasdaq
The EU regulatory submission of closed triple therapy comprises a Marketing Authorisation Application for a maintenance treatment to relieve symptoms of adult patients with COPD. It is based on data from the closed triple combination therapy ...
Japanese approval for GSK's COPD drug; EU fillingThe Pharma Letter (registration)
Glaxo files marketing application in Europe for inhaled triple combo COPD therapySeeking Alpha

all 10 news articles »

BRIEF-GSK applies for EU marketing nod for COPD drug cocktail – Reuters


BRIEF-GSK applies for EU marketing nod for COPD drug cocktail
Reuters
BRIEF-GSK applies for EU marketing nod for COPD drug cocktail. Dec 2 Glaxosmithkline Plc. * Gsk files regulatory submission in european union for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD. * Regulatory submissions ...